Decision-making for Interferon Therapy and Their Factors in Patients with Chronic Hepatitis C
-
- Katayama Taisuke
- Kyoto University Hospital
-
- Hatamochi Chieko
- College of Health and Human Sciences, Osaka Prefecture University
Bibliographic Information
- Other Title
-
- インターフェロン療法を提案されたC型慢性肝炎患者の意思決定とその要因
- インターフェロン リョウホウ オ テイアン サレタ Cガタ マンセイ カンエン カンジャ ノ イシ ケッテイ ト ソノ ヨウイン
Search this article
Abstract
This study aimed to clarify the influence of other people and the understanding of the benefits and adverse costs of IFN therapy on the decision-making of chronic hepatitis C patients to receive this therapy. An analysis of questionnaire responses and medical recordings of 89 patients indicated that the patient's opinion was the main influence in deciding to receive IFN therapy in both the treated and untreated groups. Univariate analysis revealed that while deciding to receive IFN therapy, more patients in the treated group considered the side effects to be manageable. Multivariate analysis revealed that patients who were living with family members, had a short commuting distance to the hospital, were not using television or newspapers to obtain information about the disease, and patients who believed the therapy was curative tended to begin receiving the therapy. A support system should be established for the chronic hepatitis C patients to thoroughly understand IFN therapy and to decide whether to receive this therapy. Nurses should confirm the patients' understanding about therapy and provide them with information including treatment for the side effects.
Journal
-
- Journal of Japan Society of Nursing Research
-
Journal of Japan Society of Nursing Research 35 (5), 5_57-5_66, 2012
Japan Society of Nursing Research
- Tweet
Details 詳細情報について
-
- CRID
- 1390001205740968448
-
- NII Article ID
- 130005133593
-
- NII Book ID
- AN00330079
-
- ISSN
- 02859262
- 21896100
- 21883599
-
- NDL BIB ID
- 024250675
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL
- CiNii Articles
-
- Abstract License Flag
- Disallowed